So there is hope on the horizon.
Researchers from IBM and the Institute of Bioengineering and Nanotechnology in Singapore have found a macromolecule that can be used to fight all sorts of viruses. Originally, the researchers were working on finding out what made various viruses tick, and discovered commonalities among them. That led to the development of the macromolecule.
Without getting too technical, researchers looked at glycoproteins that surround viruses and attach to the cells in someone’s body—that’s what allows viruses to spread throughout an infected person. Then, the researchers created the macromolecule, which is comprised of a host of subunits. These subunits can be amped up to help battle the viruses.
For example, one characteristic of the macromolecule is its ability to create electrostatic charges; these charges attract the virus and attach the macromolecule to it. Then, the virus can’t attach itself to healthy cells. And that means the virus can’t spread.
Researchers have tested the macromolecule on a number of viruses such as Ebola with success. And given that the macromolecule attacks the commonalities of all viruses, researchers are hopeful that they have found a “master key” to solve the problem of infection.
Still, there’s a long way to go before the macromolecule can be produced for commercial applications. Until then, we have AeraMax® Professional. So there is hope in the here and now.